Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Dawn M. Maxey

Food and Drug Administration (FDA) Postmarket Reported Side Effects and Adverse Events Associated With Pulmonary Hypertension Therapy in Pediatric Patients

Pediatric Cardiology

Child Health

Pediatrics

Cardiovascular Medicine

Perinatology

Cardiology

2013

English

Related publications

Serious Adverse Drug Events Reported to the Food and Drug Administration (FDA): Analysis of the FDA Adverse Event Reporting System (FAERS) 2006-2011 Database

English

US Food and Drug Administration Reports of Pregnancy and Pregnancy-Related Adverse Events Associated With Isotretinoin

English

Adverse Events Associated With Pediatric Use of Proton Pump Inhibitors: Analysis of the Fda Adverse Event Reporting System

English

Texas Pharmacists’ Knowledge of Reporting Serious Adverse Drug Events to the Food and Drug Administration

Journal of the American Pharmacists Association : JAPhA

Pharmacology

Pharmacy

2011

English

Adverse Events Associated With Colchicine Drug Interactions: Analysis of the Public Version of the Fda Adverse Event Reporting System

English

Reply to Cataldo (2016): Arrhythmia Associated With Buprenorphine and Methadone Reported to the Food and Drug Administration

English

Correction To: Serious Adverse Events and Fatal Adverse Events Associated With Nivolumab Treatment in Cancer Patients

Journal for ImmunoTherapy of Cancer

English

EXPRESS: Management of Prostacyclin Side Effects in Adult Patients With Pulmonary Arterial Hypertension

Pulmonary Circulation

Pulmonary

Respiratory Medicine

2017

English

Adverse Events Associated With Antibiotic Therapy in Pediatric Practice. The Role of Pre- And Probiotics in the Prevention of Antibiotic-Associated Diarrhea

Medical Council

2018

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Dawn M. Maxey

Food and Drug Administration (FDA) Postmarket Reported Side Effects and Adverse Events Associated With Pulmonary Hypertension Therapy in Pediatric Patients

Related publications

Serious Adverse Drug Events Reported to the Food and Drug Administration (FDA): Analysis of the FDA Adverse Event Reporting System (FAERS) 2006-2011 Database

US Food and Drug Administration Reports of Pregnancy and Pregnancy-Related Adverse Events Associated With Isotretinoin

Adverse Events Associated With Pediatric Use of Proton Pump Inhibitors: Analysis of the Fda Adverse Event Reporting System

Texas Pharmacists’ Knowledge of Reporting Serious Adverse Drug Events to the Food and Drug Administration

Adverse Events Associated With Colchicine Drug Interactions: Analysis of the Public Version of the Fda Adverse Event Reporting System

Reply to Cataldo (2016): Arrhythmia Associated With Buprenorphine and Methadone Reported to the Food and Drug Administration

Correction To: Serious Adverse Events and Fatal Adverse Events Associated With Nivolumab Treatment in Cancer Patients

EXPRESS: Management of Prostacyclin Side Effects in Adult Patients With Pulmonary Arterial Hypertension

Adverse Events Associated With Antibiotic Therapy in Pediatric Practice. The Role of Pre- And Probiotics in the Prevention of Antibiotic-Associated Diarrhea